Black Diamond Therapeutics, Inc.
BDTX
$3.05
$0.113.74%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 46.95% | 410.24% | 17.64% | 32.38% | -3.95% |
| Total Depreciation and Amortization | 0.00% | 1.16% | -1.16% | -25.22% | -24.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -56.54% | 35.26% | 15.27% | -49.16% | 45.02% |
| Change in Net Operating Assets | -470.97% | -15.12% | -120.79% | 99.52% | -83.37% |
| Cash from Operations | 37.80% | 351.95% | -7.87% | 38.33% | -2.49% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -73.68% | -- | -- | -- | -60.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -8,527.78% | 162.14% | 126.64% | 105.67% | -95.89% |
| Cash from Investing | -8,093.65% | 162.23% | 126.70% | 105.79% | -95.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -99.23% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.54% | -99.23% | 732.61% | -100.35% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,025.70% | 301.24% | 841.87% | -159.83% | 163.34% |